NEWSROOM All Press Releases News All April 19, 2023 Onchilles Pharma Presents at AACR 2023 New Preclinical Data on N17350, a First-in-Class Immuno-Oncology Drug Candidate with Broad, Potent, and Direct Tumor Killing Activity March 14, 2023 Onchilles Pharma Announces Presentation of Preclinical Data for N17350 at AACR 2023 December 12, 2022 Onchilles Pharma Nominates First Drug Development Candidate Targeting Neutrophil Biology for the Treatment of Cancer June 20, 2021 SDBJ: Onchilles Pharma Raises $7M for Targeted Cancer Therapy June 15, 2021 BioWorld: Onchilles looks for cancer’s Achilles heel with a $7M series A Press Releases April 19, 2023 Onchilles Pharma Presents at AACR 2023 New Preclinical Data on N17350, a First-in-Class Immuno-Oncology Drug Candidate with Broad, Potent, and Direct Tumor Killing Activity March 14, 2023 Onchilles Pharma Announces Presentation of Preclinical Data for N17350 at AACR 2023 December 12, 2022 Onchilles Pharma Nominates First Drug Development Candidate Targeting Neutrophil Biology for the Treatment of Cancer June 10, 2021 Onchilles Pharma Raises $7 Million Series A to Advance Drug Candidates to Activate Newly Discovered Broad-Acting Anticancer Pathway News June 20, 2021 SDBJ: Onchilles Pharma Raises $7M for Targeted Cancer Therapy June 15, 2021 BioWorld: Onchilles looks for cancer’s Achilles heel with a $7M series A June 10, 2021 Onchilles Pharma Raises $7 Million Series A to Advance Drug Candidates to Activate Newly Discovered Broad-Acting Anticancer Pathway June 10, 2021 Could neutrophils be the secret to cancer’s Achilles’ heel? June 10, 2021 Cancer’s Achilles Heel? UChicago Startup Secures $7 Million to Develop Unique Treatment
